We use cookies necessary to giving you a better online experience. By using our website you consent to all cookies in accordance with our Privacy Policy.
Yes, I accept
Menu
Search Opener
Seville, Spain

ICHNO 2026

Session

Friday
March 20
15:15 - 16:15
New approaches to treatment
Ian Ganly, USA;
Sandra Schmitz, Belgium
Proffered Papers
15:15 - 16:15
Therapeutic cancer vaccine VB10.16 plus pembrolizumab as 1L treatment for HPV16+ PD-L1+ r/m oropharyngeal cancer: A phase 1 dose-escalation trial
Caroline Even, France
-154
15:15 - 16:15
First Durable Clinical Response to CD47-SIRP? Blockade in Head and Neck Squamous Cell Carcinoma: Results from the HCB101 Phase 1 Trial
Alvin Luk, China
-401
15:15 - 16:15
Long-Term Outcomes Of Transoral Laser Microsurgery In Glottic Cancer: A Single-Institution Analysis
Francesco Chu, Italy
-182
15:15 - 16:15
Prospective Evaluation of Adaptive Radiotherapy in Locally Advanced Head and Neck Cancer: Dosimetric Gains and Early Clinical Outcomes
SOOREJ BALAN KALIYATH, India
-239
15:15 - 16:15
Efficacy of Extreme Radiotherapy De-escalation to Elective Nodal Beds in Head and Neck Cancer Treated with Curative Intent at a Community-Based Center
Adam Katzenberg, USA
-321
15:15 - 16:15
A Pilot Study Incorporating AI-Avatar Based Digital Engagements for Patients In A Community Radiation Oncology Practice in the USA
Adam Raben, USA
-506